This webcast will discusses the financial evaluation of late stage development of compound in the pharmaceutical industry, but the rational, methodology and analysis discussed here has universal applicability to any multi-stage product development activities across industries. We do not discuss the real options analysis here, as that is not the intended objective of this presentation. But the webcast does:
Present the case - a miniature model of a full-blown real world case
Discuss the two financial models -- the deterministic and the probabilistic models
Frame the case
Model the case
Discuss insights and results
